Skip to main content

Table 1 Patient characteristics

From: Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC

Variable

Number (%)

Total

60 (100)

Gender

 

 Male

45 (75)

 Female

15 (25)

T stage (TNM)

 

 1

13 (22)

 2

26 (43)

 3

16 (27)

 4

5 (8)

UICC stage

 

 I

10 (17)

 II

17 (28)

 III

33 (55)

  IIIA

25 (42)

  IIIB

8 (13)

Histology

 

 Adenocarcinoma

34 (57)

 Squamous cell cancer

23 (38)

 NSCLC, other

3 (5)

Localization

 

 Central

28 (47)

 Peripheral

32 (53)

Therapy

 

 Surgery

39 (65)

  Surgery only

11 (18)

  Surgery + CTx

14 (23)

  Surgery + RCTx

14 (23)

 Primary RCTx

21 (35)

  1. CTx = chemotherapy; RTx = radiotherapy; RCTx = radiochemotherapy.